LIBRELA DIN 02511819
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | BEDINVETMAB 15 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 13-Mar-2023 |
|---|
| Current status date | 13-Mar-2023 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BEDINVETMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02511797 | LIBRELA | ZOETIS CANADA INC | Solution | BEDINVETMAB 5 MG | Marketed |
| 02511800 | LIBRELA | ZOETIS CANADA INC | Solution | BEDINVETMAB 10 MG | Marketed |
| 02511827 | LIBRELA | ZOETIS CANADA INC | Solution | BEDINVETMAB 20 MG | Marketed |
| 02511835 | LIBRELA | ZOETIS CANADA INC | Solution | BEDINVETMAB 30 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 25120 | 2021-02-01 | New Drug Submission (NDS) | |
Request a quote for LIBRELA
How to read a Canadian DIN record